Search Results for: TxCell Names Lonza as its
Articles
June 6, 2018
TxCell Names Lonza as its CAR-Treg Cellular Product Manufacturer June 6, 2018
TxCell SA and Lonza Pharma & Biotech recently announced entering into a Master Service Agreement for the manufacture of TxCell’s HLA-A2 CAR-Treg cellular product (TX200), which is in development for the prevention of chronic rejection after organ transplantation.
